Article
Zidovudine treatment results in the selection of human immunodeficiency virus type 1 variants whose genotypes confer increasing levels of drug resistance.
The Journal of general virology - 1 Feb 1994
Kellam P, Boucher C A, Tijnagel J M, Larder B A
Abstract excerpt
High level resistance to 3'-azido-3'-deoxythymidine (AZT, zidovudine or Retrovir) is conferred by the presence of four or five mutations (Met-41-->Leu; Asp-67-->Asn; Lys-70-->Arg; Thr-215-->Tyr or Phe; Lys-219-->Gln) in the human immunodeficiency virus (HIV) reverse transcriptase. The order of appearance of these five mutations in asymptomatic patients during therapy has been studied. This has enabled us to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
